NCH logo

ACO

Previous names: n/a
NCH ACO, LLC
350 7th Street North
Naples, Florida 34102

ACO Governing Body

Member Name Title/Position Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if applicable
Dr. Bryan Murphey Chair 14.28% ACO Participant Representative NCHMD, Inc
Tom Thorton Member 14.28% ACO Participant Representative NCHMD, Inc
Rick Wyles Member 14.28% ACO Participant Representative NCHMD, Inc
Erin Raney Member 14.28% ACO Participant Representative NCHMD, Inc
Eileen Connolly-McDermott Member 14.28% ACO Participant Representative NCHMD, Inc
Linda Murphy Member 14.28% Medicare Beneficiary Representative n/a
Matt Heinle Member 14.28% ACO Participant Representative NCHMD, Inc

Key ACO Clinical and Administrative Leadership

  • Ricky Wyles, ACO Executive
  • Bryan Murphey, Medical Director
  • Kelly Daly, Compliance Officer
  • Georgine Kruedelbach, Quality Assurance and Improvement Officer

Associated Committees and Committee Leadership

Committee Name Committee Leader Name & Position
ACO Governing Body Dr. Bryan Murphey, Chair
Executive Committee Dr. Bryan Murphey, Chair
Quality Committee Dr. Mazen Albedalwi, Chair
Types of ACO participants, or combinations of participants, that formed the ACO
Hospital employing ACO professionals
 
SHARED SAVINGS AND LOSSES
Amount of shared Savings/Losses
  • First Agreement Period
    • Performance Year 2020, $0
    • Performance Year 2019, $0
    • Performance Year 2018, $0
Shared Savings Distribution
  • First Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • Performance Year 2019
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2018
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2020 Quality Performance Results:
ACO Quality Measure Number Measure Name Rate ACO Mean
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 1.14 0.95
ACO-13 Falls: Screening for Future Fall Risk 91.16 84.97
ACO-14 Preventive Care and Screening: Influenza Immunization 80.33 76.03
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 62.50 81.67
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow Up Plan 80.08 71.46
ACO-19 Colorectal Cancer Screening 77.20 72.59
ACO-20 Breast Cancer Screening 85.42 74.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 79.34 83.37
ACO-27 Diabetes: Hemoglobin A1c Poor Control (>9) 12.24 14.70
ACO-28 Controlling High Blood Pressure 65.72 72.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

Contact Information

Erin Raney
Eileen Connolly-McDermott

Organizational Information